Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > May 2004

« Previous month Next month »

27-May-2004

Chr Hansen steps up pharma production

27-May-2004 - Danish ingredients company Chr Hansen has ramped up its production capacity in the US for its pharmaceutical products via a $10 million (€8.2m) expansion of its facilities in Stoughton in...

Microfluidics could see off chromatography columns

27-May-2004 - Agilent Technologies has launched a microfluidics-based technology for liquid chromatography/mass spectrometry (LC/MS)- widely used by scientists in protein research and pharmaceutical applications to separate and identify biological compounds - that...

Lek expands CEE production

27-May-2004 - Novartis subsidiary Lek has opened a new plant in Romania that will supply antibiotic generics and ingredients to markets across Europe.

Lanxess names top executive

27-May-2004 - Lanxess, the fine chemicals unit that is due to be spun out of Germany's Bayer next year, will be headed by Axel Westerhaus, currently in charge of the group's polyethers...

Combo pills made simple with capsule tech

27-May-2004 - Innercap Technologies has developed a new capsule drug delivery system that makes it possible to combine two incompatible drug compounds into a single dosage unit.

26-May-2004

Ajanta may be API supplier again

26-May-2004 - India's Ajanta Pharma has said that it may re-enter the market for bulk manufacture of active pharmaceutical ingredients (APIs), despite pulling out of the sector in the late 1990s.

Coating tech licensed for improved stents

26-May-2004 - Occam International of the Netherlands has licensed its coating technology to Xtent, a company specialising in the development of cardiovascular stents that deliver drugs directly into the blood vessels.

IntroTech pushes temperature range of monitor

26-May-2004 - An unnamed European pharmaceutical company is using time temperature indicators (TTI) to ensure heart valves used in human heart transplants are kept at the optimum temperature.

Schwarz turns to drug delivery

26-May-2004 - German generics producer Schwarz Pharma has licensed rights to a drug delivery technology developed by US company Lipocine, to revamp its pipeline in the face of competitive threats to its...

Banner launches chewable gel technology

26-May-2004 - Banner Pharmaceuticals has developed a new oral delivery formulation that is designed to make it easier to dose drugs to children and the elderly and to take medications on the...

25-May-2004

Yamanouchi, Fujisawa become Astellas

25-May-2004 - Japanese drug companies Yamanouchi and Fujisawa have said that the entity to be created via their merger next year will be called Astellas Pharma, drawing on a Japanese word that...

Small pharma to get SAP inroad

25-May-2004 - IBM has launched a new software package designed to make it easier for small and medium-sized pharmaceutical and biotecnology companies to cope with the compliance requirements of the US Food...

SCOLR to go it alone after losing pharma partner

25-May-2004 - US drug delivery company SCOLR has been knocked back by the decision by one of its partners not to go ahead with a project based on its technology. But the...

Dowpharma reorganises biopharma ops

25-May-2004 - Dowpharma has unveiled plans to consolidate its biopharmaceutical custom process development activities to a single site in the US that it says will make it easier to respond to its...

Contract biopharma plant opens in Finland

25-May-2004 - In an unusual move, Finnish science park Medipolis has set up a new Good Manufacturing Practice (GMP) pilot plant to take advantage of the growing demand for biopharmaceutical production capacity.

24-May-2004

Faster chemistry with Syrris reactor

24-May-2004 - UK-based chemistry specialist Syrris has developed a new microreactor that, it claims, can speed up the optimisation of process reactions used in the drug industry.

UCB may quit chemicals sector

24-May-2004 - Belgian group UCB, fresh from making an offer for UK biotech company Celltech, has announced plans to sell off its chemicals unit and become a pharmaceuticals pure play, reports Phil...

UK announces 'shake up' of animal testing

24-May-2004 - The use of animal testing in pharmaceutical research and development is to be revised after the UK government announced it was to establish a national centre to reduce use and...

UK device maker to join US group

24-May-2004 - Respironics, a US-based company specialising in sleep and ventilation products, is to make a $44.6 million (€37.3m) cash offer for Profile Therapeutics of the UK.

Powder crusher for pharma from Nisshin

24-May-2004 - Later this month, Japan's Nisshin Engineering will launch a new product that uses airflow to pulverise materials used in pharmaceuticals. The company claims the product is cleaner to operate than...

Ivax closer to Polfa purchase?

24-May-2004 - US-headquartered generics manufacturer Ivax has cleared one obstacle in its battle to acquire a majority stake in Polish drugmaker Polfa Kutno.

Community patent dead and buried?

24-May-2004 - Ministers at the Council of the European Union dashed hopes that an EU-wide 'Community Patent' might be in the offing by voting against the measure at last week's EU Competitiveness...

20-May-2004

Merck pigments could thwart drug fakers

20-May-2004 - German pharmaceutical and chemicals supplier Merck KGaA has set up a new business unit to try and establish how some of the company's pigments can be used as brand protection...

SkyePharma lifted by US approval

20-May-2004 - UK drug delivery specialist SkyePharma received another welcome boost yesterday with the news that its new formulation of morphine had been approved in the US.

Banner tackles Japanese market

20-May-2004 - Banner Pharmacaps has entered into an agreement to introduce its non-animal-derived softgel capsules in Japan for pharmaceutical and nutritional applications.

Plant metabolism steered to drug synthesis

20-May-2004 - Researchers in Finland and Belgium have developed a new way of making plant-derived compounds in cell cultures that should cut the cost of manufacturing a raft of pharmaceuticals, including drugs...

UK start-up offers leading edge chemistry

20-May-2004 - A new company has been set up in the UK to apply high-throughput technologies to the development of new chemical materials, including catalysts and novel drugs, for use in the...

19-May-2004

Acambis seeks new customers for vaccine plant

19-May-2004 - UK biotechnology company Acambis is looking for new clients to take up unused capacity at its facility in Massachusetts, US, now that Baxter has pulled out of a manufacturing contract.

Rhodia 1Q losses worse than expected

19-May-2004 - France's Rhodia has joined its peers in the European chemicals industry in reporting some signs of a recovery in its business in the first quarter of 2004, although sales still...

Pharming bolsters transgenic platform

19-May-2004 - Pharming of the Netherlands has modified two of its commercial relationships in a move that should accelerate its activities in developing therapeutic proteins that are made in transgenic animals, writes...

Leak-testing for food packs could have pharma uses

19-May-2004 - A highly flexible automatic measuring device capable of detecting the tiniest leaks of CO2 from protective gas atmosphere packaging has been developed. While initially being targeted at the food sector,...

18-May-2004

UCB makes friendly offer for Celltech

18-May-2004 - Belgian chemicals and pharmaceuticals company UCB has made an offer to buy UK biotechnology firm Celltech for £1.53 billion (€2.25bn) in a move seen as a way of getting hold...

EC takes aim at old monographs

18-May-2004 - Companies filing for approval of new medicines may soon be forced to carry out analysis work on impurities in their products if they refer to outdated monographs, according to the...

Biotech opens door to affordable treatment

18-May-2004 - New biotechnology processes are poised to change the economics of manufacturing drugs, creating the potential for delivering both affordable medicines to patients in the developing world and laying the foundation...

Maxi use for micro mixer

18-May-2004 - A recently-introduced microstructured mixer that can provide much tighter heat and reaction control compared to conventional systems was showcased at the ACHEMASIA meeting last week.

Euro biotechs link up on cancer vaccines

18-May-2004 - A new generation of potent, targetted vaccines for cancer could be the offspring of a marriage between two technologies developed at European biotechnology companies Avidex and Active Biotech.

17-May-2004

PowderJect renewed in Chiron spin-out

17-May-2004 - The needle-free injector technology underpinning PowderJect, the drug delivery company which shot onto the biotechnology scene in the mid-1990s and was snapped up by Chiron of the US last year,...

DSM expands antibiotic intermediate capacity

17-May-2004 - DSM Anti-Infectives, the world's largest producer of antibiotics, is planning to expand a manufacturing plant for a key intermediate used in the manufacture of cephalosporins that will make it the...

EC inhaled drug guidance needs attention

17-May-2004 - The European Commission is updating its recommendations for products delivered by inhalation or intranasally, saying these no longer reflect the realities in the marketplace for these products.

Irish industry fears for pharmachem sector

17-May-2004 - Ireland's position as a hot-spot for inwards investment in pharmaceutical manufacturing is under threat from companies in the Far East and Puerto Rico, according to PharmaChemical Ireland.

Welcome deal for UK drug delivery firm

17-May-2004 - UK company SkyePharma has forged another collaboration for its drug delivery technology that could bring in up to $50 million (€42m) in milestone payments plus a hefty royalty rate on sales.

New CEO for Lonza

17-May-2004 - Directors at Swiss fine chemicals group Lonza have appointed a former BASF manager as their new chief executive, after major losses led to the resignation of Markus Gemuend earlier this...

14-May-2004

Chip-based lab cuts PCR time

14-May-2004 - A prototype chip-based laboratory developed by a German company could reduce the time it takes to carry out the DNA amplification required for polymerase chain reactions to five minutes.

13-May-2004

EU lends its weight to nanotech push

13-May-2004 - The European Commission has mapped out its strategy to keep the European Union at the forefront of research into nanotechnology, a position that is in danger of being eroded, and...

UK plans rules to hamper animal extremist efforts

13-May-2004 - The UK government has confirmed that it plans to bring in new legislation to deal with animal extremists, although the scope of the measures is still under consideration, reports Phil...

Novartis continues generics expansion

13-May-2004 - Signalling its continued commitment to the emerging economies of the recently expanded European Union, Switzerland's Novartis has unveiled a €70 million overall investment in a new generics production and logistics...

Tekni-Films claims barrier film is best-in-class

13-May-2004 - Tekni-Films has launched a new thermoformable film laminate that it claims can be used to make the highest-barrier clear blister film available on the market.

Lonza adds peptide tech to portfolio

13-May-2004 - Swiss contract manufacturing company Lonza has licensed a technology that makes it possible to make peptide drugs that are longer and have a more complex structure than is possible using...

Matthey seeks catalyst for Asian expansion

13-May-2004 - UK chemicals and metals firm Johnson Matthey has opened a precious metal process catalyst manufacturing plant in India to cater to the growing demand from the local pharmaceutical industry and...

12-May-2004

Avecia strengthens Japanese operations

12-May-2004 - Avecia Pharmaceuticals has consolidated its position in the evolving Japanese pharmaceutical market by forging a technology agreement with a local company,reports Phil Taylor.

Bayer says 1Q result is on track

12-May-2004 - German chemical company Bayer has posted flat first-quarter 2004 sales, but said that the results were on track given the negative effects of currency factors. Organic sales growth rose 8.6...

RNAi delivery achieved by atugen

12-May-2004 - Germany's atugen, a specialist in RNA interference technologies for switching off genes, has demonstrated the feasiblity of delivering a small interfering RNA (siRNA)-based drug and achieving a physiological response in...

Disposable bags for biopharma

12-May-2004 - France's Stedim and Integrated Biosystems have been awarded two new patents on their Celsius line of containers, currently being launched in Europe and US, that are used in the production...

Cut price tablet compression

12-May-2004 - A US inventor claims to have developed a process that would enable tablets to be made in three simple steps, eliminating the need for preprocessing.

Metrohm cleans up ion chromatography

12-May-2004 - Switzerland's Metrohm has developed a new delivery system for reagents used in ion chromatography that is designed to reduce wastage, improve safety in the lab and does away with the...

11-May-2004

EC, Japan close to GMP accord

11-May-2004 - The European Union and Japan have moved another step closer to recognising each other's Good Manufacturing Practice (GMP) requirements in a move that should make it easier to register and...

Fine chemicals still suffering at Degussa

11-May-2004 - Yesterday, German chemicals group Degussa said that it had got off to a good start financially in 2004. Today, the company provided a more detailed breakdown of the first-quarter results...

Generics market growing fast

11-May-2004 - The current rate of growth in the world generics market puts it on pace to outgrow branded pharmaceuticals, which will only grow by single digits in 2004, according to business...

Biotage brings microwave chemistry to single user

11-May-2004 - Sweden's Biotage has launched a system for carrying out microwave synthesis reactions that for the first time is targeted at the individual medicinal chemist.

IT at heart of future drug industry, claims IBM

11-May-2004 - Computer giant IBM claims to have identified seven key technologies that will drive innovation in the pharmaceutical industry over the next decade, raise the quality of development and manufacturing processes...

Germany to beef up science skill base

11-May-2004 - Germany has launched an initiative aimed at avoiding a shortfall of technicians into the growing areas of nanotechnology, biotechnology and microsystems technology, according to a report on the Cordis News...

10-May-2004

Topical drug delivery firm snapped up by Dr Reddy's

10-May-2004 - India's Dr Reddy's Laboratories has acquired a US company that brings in a proprietary drug delivery technology that could be applied across a whole range of dermatological products.

Mayne sets itself up in Europe with acquisition

10-May-2004 - Australia's Mayne Pharma has bought its way into the European market with the acquisition of a Germany company specialising in the manufacture of freeze dried and solution vial products for...

Printer says RFID potential is all in the validation

10-May-2004 - In March 2004, manufacturers of pharmaceuticals such as prescription painkillers and other drugs at risk of abuse were required to start using radiofrequency identification tags on all pallets destined for...

Degussa says 1Q results on track

10-May-2004 - Despite reporting a decline in revenues, Germany's third-largest chemicalscompany Degussa said that it had 'got off to a solid start' in the firstquarter of the year, ahead of presenting its...

Viral protein takes drugs into cells

10-May-2004 - A small German company has developed a new drug delivery technology that can transport active drugs into the interior of cells by an intrinsic, active mechanism.

07-May-2004

Antibiotic resistance sets the theme of ECCMID

07-May-2004 - The threat of emerging strains of bacteria with resistance to the current arsenal of drugs was the subject of intense focus as the 14th Annual European Congress on Clinical Microbiology...

Qiagen's net sales exceeded in Q1

07-May-2004 - Dutch nucleic acid specialist Qiagen reported strong growth in sales in the first quarter of 2004, ahead of its forecasts, as spending by companies in the pharmaceutical industry returns to...

RFID: An overview

07-May-2004 - RFID has arrived. Long hailed as the next IT revolution for industry, communicating labels are being forced into place by retailers and legislators alike, leaving manufacturers racing to implement a...

06-May-2004

GE unveils hardware/media marriage for purification

06-May-2004 - GE Healthcare has launched a large-scale separation system for use in the manufacture of peptide and protein drugs, which should reduce the cost and improve the purification of biopharmaceuticals.

Mixed fortunes for CEE pharma firms

06-May-2004 - Two leading central and eastern European pharma firms - both producing both generic and branded drugs and active pharmaceuticals - post results this week. Their results suggest CEE firms should...

New tests could cut animal use in toxicity studies

06-May-2004 - The number of animals tests needed for new chemicals could be reduced significantly by the use of assays tests developed by researchers at the European Commission's Joint Research Centre. And...

LION meets targets in 03/04: sees recovery this year

06-May-2004 - Two years into a major drive to exit the drug development sector and reinvent itself as an informatics pure-play, Germany's LION bioscience trimmed its net losses in the 12 months...

No more injections for bone-building drug?

06-May-2004 - A new patch product in clinical trials could provide a patient-friendly means of delivering the only drug treatment for osteoporosis that can actually replace lost bone, reports Phil Taylor.

EMEA expands responsibilities under new legislation

06-May-2004 - The structure and remit of the European Medicines Evaluation Agency (EMEA) will be overhauled from 20 May to give it a stronger advisory role to industry, the healthcare profession and patients.

Tecan reports sales of $55.6 million and net profit of $4.1 million

06-May-2004 - Swiss life sciences supplier Tecan has reported flat growth in sales but higher profits in the first quarter of 2004, which it said was largely the result of the restructuring...

05-May-2004

Teva posts loss as Sicor buy bites, but sales soar

05-May-2004 - Isael's Teva Pharmaceutical Industries slipped into a loss in the first quarter of 2004, as the cost of the acquisition of US generics and active pharmaceutical ingredient (API) firm Sicor...

Porous polymer improves asthma drug delivery

05-May-2004 - Acusphere has developed microcapsule a technology that promises to improve the delivery of a range of drugs, including those that are poorly-soluble in water. The technology is being used to...

Sigma upgrades kilo capacity with second lab

05-May-2004 - Sigma-Aldrich has expanded its contract development and manufacturing for active pharmaceutical ingredients (APIs) at its Buchs production site in Switzerland.

04-May-2004

Fisher opens custom synthesis unit in UK

04-May-2004 - Fisher Scientific has opened a new small scale chemical manufacturing facility in Loughborough, UK, to add new custom synthesis services for the pharmaceutical and other industries.

Argonaut brings parallel processing to chemistry

04-May-2004 - Process chemists who want to test a number of reactions at small-scale before ramping up to commercial production could benefit from a new system, developed by Argonaut Technologies, that can...

FDA opens new comment period on bioterrorism regs

04-May-2004 - The US Food and Drug Administration has started a new comment period on its bioterrorism regulations - designed to safeguard the national food supply - which will have a significant...

03-May-2004

CSS boosts peptide capabilities with Albachem deal

03-May-2004 - Chemical Synthesis Services of Northern Ireland has acquired a controlling interest in Albachem, a company specialising in peptide and protein synthesis based in West Lothian, Scotland.

Icon unveils plant production technology

03-May-2004 - Germany's Icon Genetics has published details of its proprietary expression technology, designed to improve the production of biopharmaceuticals and other proteins in genetically-modified plants.

FDA to tackle counterfeit drugs with new database

03-May-2004 - The US Food and Drug Administration (FDA) is planning to create a database of the major pharmaceutical brands on the US market, to make it easier to establish the authenticity...

New shredder makes drug disposal a snip

03-May-2004 - Drug companies, distributors or wholesalers sitting on a pile of expired medicines should be able to dispose of them safely using a new shredding system launched by Security Engineered Machinery.

Smart sample tech patented by Applera

03-May-2004 - Applera has been awarded a broad US patent covering the use of microdevices with built-in electronic memory that can be used for storing and retrieving information about samples used in...

US lab supplies firms post bumper 1Q results

03-May-2004 - The raft of US laboratory equipment and consumables companies reporting results for the first quarter of 2004 this week provides convincing evidence that demand for these products has returned among...

RNAi markets set for strong growth

03-May-2004 - The market for RNA interference (RNAi) products used as research tools and therapeutics is still at an embryonic stage, but looks set to more than double in value by the...

« Previous month Next month »